Your browser doesn't support javascript.
loading
Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study.
O'Malley, D M; Bariani, G M; Cassier, P A; Marabelle, A; Hansen, A R; De Jesus Acosta, A; Miller, W H; Safra, T; Italiano, A; Mileshkin, L; Amonkar, M; Yao, L; Jin, F; Norwood, K; Maio, M.
  • O'Malley DM; The Ohio State University Wexner Medical Center and The James Comprehensive Cancer Center, Columbus, OH, USA. Electronic address: David.O'Malley@osumc.edu.
  • Bariani GM; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil. Electronic address: bariani@yahoo.com.
  • Cassier PA; Centre Léon Bérard, Lyon, France. Electronic address: philippe.cassier@lyon.unicancer.fr.
  • Marabelle A; Gustave Roussy, Institut National de la Santé et de la Recherche Médicale U1015 & CIC1428, Université Paris Saclay, Villejuif, France. Electronic address: Aurelien.Marabelle@gustaveroussy.fr.
  • Hansen AR; Princess Margaret Cancer Centre, Toronto, ON, Canada. Electronic address: aaron.hansen@uhn.ca.
  • De Jesus Acosta A; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. Electronic address: adejesu1@jhmi.edu.
  • Miller WH; Segal Cancer Centre, Jewish General Hospital, Rossy Cancer Network, McGill University, Montreal, QC, Canada. Electronic address: wilsonmiller@gmail.com.
  • Safra T; Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: tamars@tlvmc.gov.il.
  • Italiano A; Early Phase Trials Unit, Institut Bergonié and Faculty of Medicine, University of Bordeaux, Bordeaux, France. Electronic address: A.Italiano@bordeaux.unicancer.fr.
  • Mileshkin L; Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: linda.mileshkin@petermac.org.
  • Amonkar M; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: mayur.amonkar@merck.com.
  • Yao L; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: lili.yao@merck.com.
  • Jin F; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: fan.jin@merck.com.
  • Norwood K; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: kevin.norwood@merck.com.
  • Maio M; University of Siena and Center for Immuno-Oncology, Department of Oncology, University Hospital, Siena, Italy. Electronic address: maio@unisi.it.
Gynecol Oncol ; 166(2): 245-253, 2022 08.
Article en En | MEDLINE | ID: mdl-35835611
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Endometriales Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Endometriales Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article